Stomach Diseases clinical trials
The registry lists 53 studies for Stomach Diseases across more than 10 countries. 6 are recruiting or about to start. 24 of them are mainly about Stomach Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-06-24. Counting its 14 narrower conditions too, such as Stomach Neoplasms: 4,370 studies, 1,185 open.
Get an email when these change. Save the Stomach Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Who runs them
Changhai Hospital (6) · Nihon Pharmaceutical Co., Ltd (2) · Shandong University (2) · Novartis Pharmaceuticals (2) · Affiliated Hospital to Academy of Military Medical Sciences (2) · Evoke Pharma (2) · Inonu University (2) · The SmartPill Corporation (2)
What is being tested here
Drugs under test in Stomach Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted
| Drug | Open | Phase 3 | All |
|---|---|---|---|
| Metoclopramide | 0 | 2 | 2 |
| Levomenthol | 0 | 2 | 2 |
| L-menthol Preparation NPO-11 | 0 | 2 | 2 |
| Camrelizumab | 0 | 0 | 1 |
| Esomeprazole | 0 | 0 | 1 |
| Ocoxin | 0 | 0 | 1 |
| Acetaminophen | 0 | 0 | 1 |
| Dovitinib | 0 | 0 | 1 |
| Everolimus | 0 | 1 | 1 |
| TachoSil | 0 | 0 | 1 |
Drug classes tested here Antiemetics 3
Who these studies take
Of the 2 Stomach Diseases studies recruiting now, 0 (0%) set no upper age limit and 1 (50%) stop at 75 or younger. 0 (0%) take children under 18. 0 (0%) are for women only and 0 (0%) for men only; 0 (0%) take healthy volunteers.
| Age | Women | Men |
|---|---|---|
| 10 | 0 (0%) | 0 (0%) |
| 18 | 2 (100%) | 2 (100%) |
| 30 | 2 (100%) | 2 (100%) |
| 40 | 2 (100%) | 2 (100%) |
| 50 | 2 (100%) | 2 (100%) |
| 65 | 1 (50%) | 1 (50%) |
| 75 | 1 (50%) | 1 (50%) |
| 85 | 0 (0%) | 0 (0%) |
Across all 53 studies, recruiting or not: 40% stop at 75 or younger and 15% at 65; 9% take children; 2% are for women only and 2% for men only; 30% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.
Studies
Recruiting first, then most recently updated. Showing 50 of 53. Browse all 53 → or search them.
- One-Click Autofocus Versus Segmented Focus in Gastric EndoscopyNot yet recruitingNCT07664813Not applicable1 country
- Study of Gastric Motility in Eosinophilic GastritisRecruitingNCT052294321 country
- Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric CancerRecruitingNCT073135791 country
- Post-market Clinical Follow-up of Disposable Endoscope Linear Cutting Staplers and ComponentsNot yet recruitingNCT065552761 country
- The Effect of Oxygen Application With Double Nasal Cannula on Respiratory ComplicationsNot yet recruitingNCT06273319Not applicable1 country
- PillBot™ - Remotely Controlled Capsule EndoscopyNot yet recruitingNCT06212206Not applicable
- Novel Endoscopic Bite BlockCompletedNCT06958250Not applicable1 country
- Efficacy and Safety of Benralizumab in Patients With Eosinophilic Gastritis and/or Gastroenteritis (The HUDSON GI Study)TerminatedNCT05251909Phase 39 countries
- Diet Intervention on Obesity Related ComplicationActive, not recruitingNCT06719466Not applicable1 country
- Screening for Stomach Diseases and Colorectal Neoplasms With the Fecal TestingCompletedNCT01741363Not applicable1 country
- Evaluation of Ocoxin®-Viusid® in Advanced Stomach Cancer and Gastric Esophagogastric JunctionCompletedNCT03549494Phase 21 country
- Fully Closed-Loop Insulin Delivery in Abdominal Surgery (CLAB)CompletedNCT05392452Not applicable1 country
- Efficacy and Safety of SOX Regimen Combined With Camrelizumab as Neoadjuvant Treatment in Locally Advanced Gastric Cancer: a Phase II, Single-arm StudyActive, not recruitingNCT05602935Phase 21 country
- The Usage of Soda-Water in Gastric Preparation for Magnetically Controlled Capsule EndoscopyCompletedNCT04479423Not applicable1 country
- PROGRESSive Withdrawal Esomeprazole and Acid-related SymptomsActive, not recruitingNCT02476097Phase 41 country
- A Study to Evaluate Endoscopic Visibility of Stomach After a Combination Drink of N-acetylcysteine and SimethiconeStatus unknownNCT05801055Phase 31 country
- Tongue Image Database and Diagnostic Model for Digestive Tract Disease DiagnosisCompletedNCT051829831 country
- Automatic Real-time Diagnosis of Gastric Mucosal Disease Using pCLE With Artificial IntelligenceCompletedNCT037842091 country
- Pronase Granules in Gastric CleaningStatus unknownNCT05249933Phase 2/31 country
- Magnetically Controlled Capsule Endoscopy in Visualization of the UGI and Small IntestineStatus unknownNCT050692331 country
- IV Acetaminophen for Post-Operative Pain Management in Enhanced Recovery After Surgery (ERAS) PopulationCompletedNCT03198871Phase 41 country
- Gastroplasty and Electrical Impedance TomographyCompletedNCT03476863Not applicable1 country
- Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men With Diabetic GastroparesisCompletedNCT02025751Phase 31 country
- Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic GastroparesisCompletedNCT02025725Phase 31 country
- Diagnosis of Gastric Lesions From Exhaled Breath and SalivaCompletedNCT014205882 countries
- Transoral Removal of Specimen During Laparoscopic Gastric ResectionCompletedNCT041113931 country
- Application of Simethicone in EsophagogastroscopyCompletedNCT03776916Not applicable1 country
- Repetitive Position Change Improves Gastric Cleanliness for MCECompletedNCT03514966Not applicable1 country
- Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal CancersTerminatedNCT03122548Phase 21 country
- The Maintenance Treatment of Apatinib/Capecitabine Versus Observation in Advanced Gastric CancerStatus unknownNCT03889626Phase 3
- Indications and Outcomes of Endoscopic Ultrasound in TantaStatus unknownNCT03267355Not applicable1 country
- Linked Color Imaging Based CMV Diagnosis for Gastric Mucosal LesionsStatus unknownNCT03092414Not applicable1 country
- A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma PatientsCompletedNCT01576380Phase 21 country
- Gastric Emptying: in Vivo Studies in Healthy VolunteersStatus unknownNCT02994472Not applicable
- Domperidone for Refractory Gastrointestinal DisordersStatus unknownNCT00777439Not applicable1 country
- Gastric Preparation of Magnetic-controlled Capsule EndoscopyStatus unknownNCT02846155Phase 21 country
- Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)CompletedNCT00879333Phase 322 countries
- Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric DiseasesCompletedNCT02219529Phase 31 country
- Safety and Feasibility of TachoSil®: Application on Esophageal AnastomosesCompletedNCT02105506Not applicable1 country
- High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori EradicationCompletedNCT01888237Phase 41 country
- Feasibility Trial to Evaluate the Ability of the SuMO Tissue Access and Resection SystemCompletedNCT01322737Not applicable1 country
- Prognosis of Signet Ring Cells in Upper Digestive NeoplasmsCompletedNCT012498591 country
- Daily Tadalafil and Gastric Emptying Time in Diabetic GastroparesisWithdrawnNCT01326117Phase 41 country
- Effect of "Sekanjabin e Safarjali" (Quince Oxymel) in the Prevention of Migraine AttacksStatus unknownNCT02179775Not applicable1 country
- Transit Time and Bacterial Overgrowth Using SmartPill CapsuleTerminatedNCT00577772Not applicable1 country
- Assessment of the Effect of Tegaserod (2 mg Tid and 6 mg Tid) on Dyspeptic Symptoms in Diabetic Patients With Symptoms of Diabetic GastropathyTerminatedNCT00142974Phase 21 country
- An Efficacy and Safety Study of Cisapride in Patients With Chronic Gastroparesis After Failure of Other Treatment OptionsTerminatedNCT01281540Phase 4
- Phase III Controlled Clinical Study of NPO-11 in Patients Undergoing Gastric EndoscopyCompletedNCT00742599Phase 31 country
- Phase III General Clinical Study of NPO-11 in Patients Undergoing Gastric EndoscopyCompletedNCT00745459Phase 31 country
- Risk Factors for Gastric Disease in Pediatric Helicobacter Pylori (H. Pylori)CompletedNCT002122251 country